<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:d1704d44-4cb0-45e5-a8ef-4e87057ac2b9,g:a09032b6-5d36-4c3e-9be6-6aba698f40b1,d:bd4aac70ee7f478ea1398f0184343985--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sppi-20210617</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV80L2ZyYWc6ZTg3NDU4MGU2Zjg3NDBkNDlkNTNmNDFkYTFiNDMwNDcvdGFibGU6MzU4OWI4YjdhODA0NDZiNjhiOTcwODBhY2RmODEwOGYvdGFibGVyYW5nZTozNTg5YjhiN2E4MDQ0NmI2OGI5NzA4MGFjZGY4MTA4Zl8yLTEtMS0xLTA_22f7505a-d326-447b-b397-9d9b9baeaba5">false</ix:nonNumeric><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV80L2ZyYWc6ZTg3NDU4MGU2Zjg3NDBkNDlkNTNmNDFkYTFiNDMwNDcvdGFibGU6MzU4OWI4YjdhODA0NDZiNjhiOTcwODBhY2RmODEwOGYvdGFibGVyYW5nZTozNTg5YjhiN2E4MDQ0NmI2OGI5NzA4MGFjZGY4MTA4Zl8zLTEtMS0xLTA_f9599ed8-3eba-4bf2-b90d-716def86f9cc">0000831547</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sppi-20210617.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i53609480138740f79ae3eaaa753575f4_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000831547</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i685f79d1e156414bbb335c70c19a6237_D20210528-20210528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000831547</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-28</xbrli:startDate><xbrli:endDate>2021-05-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ibd4aac70ee7f478ea1398f0184343985_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGV4dHJlZ2lvbjozZTJkYjIwYzI0ZDY0ZDI2YmE5MzY5MDA2MGUyMjI3ZF8xNjE3_2c2744c3-6452-4436-adc4-98e7e2243c26">8-K</ix:nonNumeric> </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGV4dHJlZ2lvbjozZTJkYjIwYzI0ZDY0ZDI2YmE5MzY5MDA2MGUyMjI3ZF8yMzg_16084408-6e09-44a6-8e59-a627a69ee7e8">June 17, 2021</ix:nonNumeric> </span></div><div style="margin-top:24pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGV4dHJlZ2lvbjozZTJkYjIwYzI0ZDY0ZDI2YmE5MzY5MDA2MGUyMjI3ZF8xNjIx_e9f49923-d0bd-4867-80cc-32339116b4ad">SPECTRUM PHARMACEUTICALS INC</ix:nonNumeric> </span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i685f79d1e156414bbb335c70c19a6237_D20210528-20210528" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGFibGU6YzQzMmI4ZWUzNDA1NDViMWI3ZjgyMjZhZTk3ZDRlZjMvdGFibGVyYW5nZTpjNDMyYjhlZTM0MDU0NWIxYjdmODIyNmFlOTdkNGVmM18wLTAtMS0xLTA_5510e6ef-ac8f-4c15-b25f-c0bd054b20d1">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGFibGU6YzQzMmI4ZWUzNDA1NDViMWI3ZjgyMjZhZTk3ZDRlZjMvdGFibGVyYW5nZTpjNDMyYjhlZTM0MDU0NWIxYjdmODIyNmFlOTdkNGVmM18wLTEtMS0xLTA_1dcd2cfa-333c-419b-a94d-db266f2b80e4">001-35006</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGFibGU6YzQzMmI4ZWUzNDA1NDViMWI3ZjgyMjZhZTk3ZDRlZjMvdGFibGVyYW5nZTpjNDMyYjhlZTM0MDU0NWIxYjdmODIyNmFlOTdkNGVmM18wLTItMS0xLTA_1d1bea69-3926-40df-9a37-015d939cfcf5">93-0979187</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction <br/>of incorporation)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission <br/>File Number)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer <br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.281%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i685f79d1e156414bbb335c70c19a6237_D20210528-20210528" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGFibGU6ZjQ4NjYxMzc1OGFjNDYxM2I0MDM1NGVmNzVjOGU5NjgvdGFibGVyYW5nZTpmNDg2NjEzNzU4YWM0NjEzYjQwMzU0ZWY3NWM4ZTk2OF8wLTAtMS0xLTA_773555bb-3859-46cc-80b7-7f4d87d1fd62">11500 South Eastern Avenue</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i685f79d1e156414bbb335c70c19a6237_D20210528-20210528" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGFibGU6ZjQ4NjYxMzc1OGFjNDYxM2I0MDM1NGVmNzVjOGU5NjgvdGFibGVyYW5nZTpmNDg2NjEzNzU4YWM0NjEzYjQwMzU0ZWY3NWM4ZTk2OF8wLTEtMS0xLTA_089649d2-ee52-4140-a6b9-0fee44340550">Suite 240</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGFibGU6ZjQ4NjYxMzc1OGFjNDYxM2I0MDM1NGVmNzVjOGU5NjgvdGFibGVyYW5nZTpmNDg2NjEzNzU4YWM0NjEzYjQwMzU0ZWY3NWM4ZTk2OF8wLTItMS0xLTA_0c7a9906-2efd-42b8-817f-fdb6211d08f4">Henderson</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i685f79d1e156414bbb335c70c19a6237_D20210528-20210528" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGFibGU6ZjQ4NjYxMzc1OGFjNDYxM2I0MDM1NGVmNzVjOGU5NjgvdGFibGVyYW5nZTpmNDg2NjEzNzU4YWM0NjEzYjQwMzU0ZWY3NWM4ZTk2OF8wLTMtMS0xLTA_7a7b4457-c541-47d7-ba4a-0bcddbaa7b08">Nevada</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i685f79d1e156414bbb335c70c19a6237_D20210528-20210528" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGFibGU6ZjQ4NjYxMzc1OGFjNDYxM2I0MDM1NGVmNzVjOGU5NjgvdGFibGVyYW5nZTpmNDg2NjEzNzU4YWM0NjEzYjQwMzU0ZWY3NWM4ZTk2OF8wLTQtMS0xLTA_cfc55ffa-b713-47b5-863e-aff3a02959db">89052</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGV4dHJlZ2lvbjozZTJkYjIwYzI0ZDY0ZDI2YmE5MzY5MDA2MGUyMjI3ZF8xNjE4_f4209089-d70a-44a4-ba81-84a47cfa8431">702</ix:nonNumeric>) <ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGV4dHJlZ2lvbjozZTJkYjIwYzI0ZDY0ZDI2YmE5MzY5MDA2MGUyMjI3ZF8xNjIy_073e5ac5-ee46-4911-bc2d-a12243248325">835-6300</ix:nonNumeric> </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address if changed since last report.)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGV4dHJlZ2lvbjozZTJkYjIwYzI0ZDY0ZDI2YmE5MzY5MDA2MGUyMjI3ZF8xNjE5_6d8172ce-2715-4666-8bc2-5ce3ace25e15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGV4dHJlZ2lvbjozZTJkYjIwYzI0ZDY0ZDI2YmE5MzY5MDA2MGUyMjI3ZF8xNjIw_09020712-d001-469b-b0be-f76458d1446d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGV4dHJlZ2lvbjozZTJkYjIwYzI0ZDY0ZDI2YmE5MzY5MDA2MGUyMjI3ZF8xNjIz_77e2d9fd-d09d-4267-9b9b-491cb6b48d38">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGV4dHJlZ2lvbjozZTJkYjIwYzI0ZDY0ZDI2YmE5MzY5MDA2MGUyMjI3ZF8xNjI0_c2e847e2-e879-4c39-abd9-fa0b39381dd8">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div style="margin-bottom:6pt;margin-top:21pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGFibGU6Y2RhYTk4YTI0NTZjNDIxZmIzYTU1MDEzMjg4MzZmNzMvdGFibGVyYW5nZTpjZGFhOThhMjQ1NmM0MjFmYjNhNTUwMTMyODgzNmY3M18xLTAtMS0xLTA_d8946bf4-09e6-46aa-ada2-6ab6c2ee1d8e">Common Stock, $0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGFibGU6Y2RhYTk4YTI0NTZjNDIxZmIzYTU1MDEzMjg4MzZmNzMvdGFibGVyYW5nZTpjZGFhOThhMjQ1NmM0MjFmYjNhNTUwMTMyODgzNmY3M18xLTEtMS0xLTA_c005f2b1-87af-4ffd-8931-1ed0fc83a9de">SPPI</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGFibGU6Y2RhYTk4YTI0NTZjNDIxZmIzYTU1MDEzMjg4MzZmNzMvdGFibGVyYW5nZTpjZGFhOThhMjQ1NmM0MjFmYjNhNTUwMTMyODgzNmY3M18xLTItMS0xLTA_6fe97a8a-91eb-471b-8d63-5406c058f396">The NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).   Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i53609480138740f79ae3eaaa753575f4_D20210617-20210617" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmJkNGFhYzcwZWU3ZjQ3OGVhMTM5OGYwMTg0MzQzOTg1L3NlYzpiZDRhYWM3MGVlN2Y0NzhlYTEzOThmMDE4NDM0Mzk4NV8xL2ZyYWc6M2UyZGIyMGMyNGQ2NGQyNmJhOTM2OTAwNjBlMjIyN2QvdGV4dHJlZ2lvbjozZTJkYjIwYzI0ZDY0ZDI2YmE5MzY5MDA2MGUyMjI3ZF8xNjI1_6079a30a-acb8-4f26-bf46-ba193900f4b0">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ibd4aac70ee7f478ea1398f0184343985_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:7.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 5.07&#160;&#160;&#160;&#160;Submission of Matters to a Vote of Security Holders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Spectrum Pharmaceuticals, Inc. (the &#8220;Company&#8221;) held its 2021 annual meeting of stockholders (the &#8220;Annual Meeting&#8221;) on June 17, 2021 at the Company&#8217;s corporate headquarters located at 11500 S. Eastern Avenue, Suite 240, Henderson, Nevada 89052.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">As of the close of business on April 20, 2021, the record date for the Annual Meeting, a total of 155,713,230 shares were outstanding and entitled to vote, of which a total of 106,681,573 shares were present in person or by proxy at the Annual Meeting, constituting a quorum for the conduct of business thereat.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The following sets forth detailed information regarding the voting results at the Annual Meeting for each of the matters voted upon by the stockholders.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">These matters are described in more detail in the Company&#8217;s Definitive Proxy Statement for its Annual Meeting of Stockholders filed with the Securities and Exchange Commission on April 21, 2021 (the &#8220;Proxy Statement&#8221;).</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%;text-decoration:underline">Proposal No. 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The Company&#8217;s stockholders elected each of the seven nominees named below to serve on the Board of Directors of the Company for a one-year term expiring at the annual meeting of stockholders in 2022 and until their respective successors are duly elected and qualified, or until their earlier resignation or removal.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:475.50pt"><tr><td style="width:1.0pt"></td><td style="width:144.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:69.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:96.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:94.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:3pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Nominee</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:3pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:3pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Abstentions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:3pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:3pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">William L. Ashton</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,591,525</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264,965</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,988</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367,095</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:3pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nora E. Brennan</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,250,330</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637,135</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427,013</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367,095</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:3pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Seth H.Z. Fischer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,679,081</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,185,138</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,259</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367,095</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:3pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Joseph W. Turgeon</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,018,497</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,866,293</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429,688</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367,095</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:3pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Jeffrey L. Vacirca, M.D., FACP</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,048,340</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,782,897</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,241</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367,095</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:3pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dolatrai M. Vyas, Ph.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,565,401</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,297,537</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,540</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367,095</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:3pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Bernice R. Welles, M.D., M.B.A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,002,308</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,884,751</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427,419</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367,095</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%;text-decoration:underline">Proposal No. 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The Company&#8217;s stockholders approved by advisory vote the compensation of the Company&#8217;s named executive officers, as disclosed in the Compensation Discussion and Analysis section of the Proxy Statement.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.811%"><tr><td style="width:1.0%"></td><td style="width:18.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.696%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:39pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:39pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:39pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Abstentions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:39pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,208,187</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,439,741</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,550</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367,095</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">Item 9.01             Financial Statements and Exhibits.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">(d) Exhibits</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit No.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">          </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Description</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">104</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">              &#160;&#160;&#160;&#160;     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">C</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">over Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL)</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ibd4aac70ee7f478ea1398f0184343985_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:11.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:7.5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:7.5pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:137.25pt;padding-right:137.25pt;text-align:center;text-indent:-20.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SPECTRUM PHARMACEUTICALS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 22, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kurt A. Gustafson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kurt A. Gustafson <br/>Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "sppi-20210617.htm", "description": "8-K", "secsgml_size_bytes": 47281}]
{"company-data": {"conformed-name": "SPECTRUM PHARMACEUTICALS INC", "cik": "0000831547", "assigned-sic": "2834", "irs-number": "930979187", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-35006", "film-number": "211035581"}, "business-address": {"street1": "11500 S. EASTERN AVE., SUITE 240", "city": "HENDERSON", "state": "NV", "zip": "89052", "phone": "702-835-6300"}, "mail-address": {"street1": "11500 S. EASTERN AVE., SUITE 240", "city": "HENDERSON", "state": "NV", "zip": "89052"}, "former-company": [{"former-conformed-name": "NEOTHERAPEUTICS INC", "date-changed": "19960819"}, {"former-conformed-name": "AMERICUS FUNDING CORP", "date-changed": "19920703"}]}
sppi-20210617
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
_______________
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 17, 2021
SPECTRUM PHARMACEUTICALS INC
(Exact name of registrant as specified in its charter)
Delaware
001-35006
93-0979187
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
11500 South Eastern Avenue
Suite 240
Henderson
Nevada
89052
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code:
(
702
)
835-6300
Not Applicable
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 par value
SPPI
The NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.07    Submission of Matters to a Vote of Security Holders.
Spectrum Pharmaceuticals, Inc. (the "Company") held its 2021 annual meeting of stockholders (the "Annual Meeting") on June 17, 2021 at the Company's corporate headquarters located at 11500 S. Eastern Avenue, Suite 240, Henderson, Nevada 89052.
As of the close of business on April 20, 2021, the record date for the Annual Meeting, a total of 155,713,230 shares were outstanding and entitled to vote, of which a total of 106,681,573 shares were present in person or by proxy at the Annual Meeting, constituting a quorum for the conduct of business thereat.
The following sets forth detailed information regarding the voting results at the Annual Meeting for each of the matters voted upon by the stockholders.
These matters are described in more detail in the Company's Definitive Proxy Statement for its Annual Meeting of Stockholders filed with the Securities and Exchange Commission on April 21, 2021 (the "Proxy Statement").
Proposal No. 1
:
The Company's stockholders elected each of the seven nominees named below to serve on the Board of Directors of the Company for a one-year term expiring at the annual meeting of stockholders in 2022 and until their respective successors are duly elected and qualified, or until their earlier resignation or removal.
Nominee
Votes For
Votes Against
Abstentions
Broker Non-Votes
William L. Ashton
83,591,525
2,264,965
457,988
20,367,095
Nora E. Brennan
84,250,330
1,637,135
427,013
20,367,095
Seth H.Z. Fischer
83,679,081
2,185,138
450,259
20,367,095
Joseph W. Turgeon
84,018,497
1,866,293
429,688
20,367,095
Jeffrey L. Vacirca, M.D., FACP
83,048,340
2,782,897
483,241
20,367,095
Dolatrai M. Vyas, Ph.D.
83,565,401
2,297,537
451,540
20,367,095
Bernice R. Welles, M.D., M.B.A.
83,002,308
2,884,751
427,419
20,367,095
Proposal No. 2
:
The Company's stockholders approved by advisory vote the compensation of the Company's named executive officers, as disclosed in the Compensation Discussion and Analysis section of the Proxy Statement.
Votes For
Votes Against
Abstentions
Broker Non-Votes
81,208,187
4,439,741
666,550
20,367,095
Item 9.01             Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
Description
104
C
over Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SPECTRUM PHARMACEUTICALS, INC.
Date:
June 22, 2021
By:
/s/ Kurt A. Gustafson
Kurt A. Gustafson
Executive Vice President and Chief Financial Officer